Need for Blood Substitutes amid Coronavirus Outbreak Fuels Demand for PFC Fluids

1. Need for Blood Substitutes amid Coronavirus Outbreak Fuels Demand for PFC Fluids As the COVID-19 situation persists, experts are warning of shortage of blood. This has increased pressure on the federal government in the U.S. to approve and begin manufacturing of oxygen therapeutics and blood substitutes. Thus, pharmaceutical technologies such as hemoglobin-based (human and bovine) oxygen carriers (HBOCs) and perfluorocarbon (PFC) fluids and emulsions are emerging as blood substitutes. Such trends are creating incremental opportunities for pharmaceutical companies in the perfluorocarbons market during the pandemic. Although companies in the perfluorocarbons market are considering blood substitutes as a silver lining, industries such as semiconductor cleaning, cosmetics, and electrical processing are experiencing a downtick in the demand from consumers. Hence, manufacturers should focus on business continuity for essential industries including medical and for refrigerant applications to establish stable revenue flow. Request https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep _id=14486 A Sample- PFC Artificial Blood May Lead to Reduced Platelet Count Manufacturers are increasing their production capabilities in perfluorocarbon artificial blood by adding water, salt, and phospholipid surfactants, which is then used as a solution to emulsify through high-pressure homogenization. However, downsides of perfluorocarbons include reduced platelet count in the blood, which may cause flu- like symptoms. Hence, pharmaceutical companies in the perfluorocarbons market are establishing a strong research base for clinical trials by making adjustments to PFCs in order to minimize its side effects. Companies are developing stable perfluorocarbon nano-emulsions that avoid fast clearance from blood and deliver long organ retention time. Cosmetics Manufacturers Focus on Anti-ageing Benefits of PFCs Since an increasing number of consumers is opting for celebrity endorsed oxygen facial products, manufacturers in the perfluorocarbons market are mainly focusing on cosmetics and personal care products. Circcell Skincare - a provider of luxury skin care products online is taking advantage of this opportunity to offer ABO +|- face and eye serums that harness the benefits of medical-grade PFCs. Consumers are choosing skincare products that support cellular respiration, diminish puffiness under eyes, and smoothen wrinkles & fine lines. Advantages of PFCs

2. including skin rejuvenation, healing scars & wounds, and brightening skin complexion are proving beneficial for personal care product manufacturers in the perfluorocarbons market. Perfluorocarbons also increase collagen production and encourage micro- circulation in the skin. Purchase https://www.transparencymarketresearch.com/checkout.php?rep_id=14486&lt ype=S A Report- Anthropogenic Production of PFCs for Semiconductor Cleaning Minimizes Global Warming The perfluorocarbons market is expected to progress at a modest CAGR of ~4% during the assessment period. This is evident since perfluorocarbons used for semiconductor cleaning are potential greenhouse gases (GHG) that result in ozone depletion. Thus, pure fluorine is emerging as a substitute to PFC cleaning gas whilst affecting sales of the latter. Hence, manufacturers are resorting to anthropogenic production of PFCs to reduce global warming. The semiconductor exhaust gas treatment is being achieved with the help of perfluorocarbons. Such trends are helping manufacturers to drive the use of perfluorocarbons in semiconductor applications. Semiconductor fabs are needing perfluorocarbons that accurately and precisely control surface temperatures of different components in the vacuum train and exhaust gas handling systems. Liquid PFC Coated Peripherally Inserted Central Catheters Reduce Clotting, Infections Thrombosis and infections are inter-related problems associated with the use of central nervous catheters (CVL). Companies in the perfluorocarbons market are capitalizing on this opportunity by increasing the availability of antibiotic-free, fluoropolymer-immobilized, liquid PFC coated peripherally inserted central catheters (PICC) line, which reduced thrombosis and pathogen colonization. Manufacturers are increasing efforts to modify polyurethane PICC catheters by a three-step lamination process with thin fluoropolymer layers before applying the liquid perfluorocarbon. The high throughput process of modifying commercial PICC catheters with fluoropolymer is benefitting companies in the perfluorocarbons market. This method is being highly publicized as a quick and safe procedure to demonstrate higher thrombo-resistance than fluorinated, omniphobic catheter surfaces.